PatientsVille.com Logo

PatientsVille

Olopatadine Side Effects

Common Olopatadine Side Effects


The most commonly reported Olopatadine side effects (click to view or check a box to report):

Hepatic Function Abnormal (3)
Aspartate Aminotransferase Increased (3)
Circulatory Collapse (2)
Alanine Aminotransferase Increased (2)
Haematocrit Increased (2)
Dizziness (2)
Pyrexia (2)
Arrhythmia (2)
White Blood Cell Count Increased (2)
Blood Pressure Decreased (2)
Cardiac Arrest (2)
Malaise (2)
Bradycardia (2)
Blood Creatinine Increased (2)
Arthralgia (1)
Apraxia (1)
Asthenia (1)
Constipation (1)
Psychotic Disorder (1)
Autonomic Neuropathy (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Olopatadine Side Effects Reported to FDA

The following Olopatadine reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Olopatadine on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Anosmia
This is a report of a 56-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: seasonal allergic rhinitis, who was treated with Olopatadine (dosage: 2 Spray In Each Postril, start time: Oct 01, 2012), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Anosmia
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Olopatadine treatment in female patients, resulting in anosmia side effect.

Renal Impairment
This report suggests a potential Olopatadine Hcl Renal Impairment side effect(s) that can have serious consequences. A 42-year-old male patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: NA and used Olopatadine Hcl (dosage: Unk) starting Apr 12, 2012. Soon after starting Olopatadine Hcl the patient began experiencing various side effects, including:
  • Renal Impairment
Drugs used concurrently:
  • Lipitor
  • Diovan (Unk)
  • Allegra (Unk)
Although Olopatadine Hcl demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as renal impairment, may still occur.

Blood Potassium Increased, Renal Disorder, Haemoglobin Decreased, Acute Respiratory Failure, Blood Creatinine Increased, Haematocrit Decreased, Blood Alkaline Phosphatase Increased, Blood Urea Increased
This Blood Potassium Increased, Renal Disorder, Haemoglobin Decreased, Acute Respiratory Failure, Blood Creatinine Increased, Haematocrit Decreased, Blood Alkaline Phosphatase Increased, Blood Urea Increased problem was reported by a consumer or non-health professional from JAPAN. A 78-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Dec 16, 2011 this consumer started treatment with Olopatadine Hcl (dosage: NA). The following drugs were being taken at the same time:
  • Lansoprazole
  • Loxonin
  • Glufast
  • Antebate
  • Prednisolone
  • Prednisolone
  • Zolinza (400 Mg/daily Po, 100 Mg/daily Po, 200 Mg/daily Po)
  • Zolinza (400 Mg/daily Po, 100 Mg/daily Po, 200 Mg/daily Po)
When commencing Olopatadine Hcl, the patient experienced the following unwanted symptoms/side effects:
  • Blood Potassium Increased
  • Renal Disorder
  • Haemoglobin Decreased
  • Acute Respiratory Failure
  • Blood Creatinine Increased
  • Haematocrit Decreased
  • Blood Alkaline Phosphatase Increased
  • Blood Urea Increased
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as blood potassium increased, may become evident only after a product is in use by the general population.

Toxic Skin Eruption
This is a report of a 69-year-old female patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: NA and was treated with Olopatadine Hcl (dosage: NA) starting Mar 14, 2012. Concurrently used drugs:
  • Galantamine Hydrobromide
  • Aspirin Dialuminate
  • Norvasc
Soon after that, the consumer experienced the following side effects:
  • Toxic Skin Eruption
This opens a possibility that Olopatadine Hcl treatment could cause the above reactions, including toxic skin eruption, and some female subjects may be more susceptible.


Aggression, Suicide Attempt
A 39-year-old female patient (weight: NA) from JAPAN with the following symptoms/conditions: seasonal allergy started Olopatadine Hcl treatment (dosage: Unk) on Oct 01, 2011. Soon after starting Olopatadine Hcl treatment, the subject experienced various side effects, including:
  • Aggression
  • Suicide Attempt
Concurrently used drugs:
  • Litiomal
  • Clonazepam
  • Goodmin
  • Yaz (1 Df, Qd)
  • Eticalm
This finding indicates that some female patients could be more vulnerable to Olopatadine Hcl.

Juvenile Arthritis, Hepatic Function Abnormal
A female patient from JAPAN (weight: NA) experienced symptoms, such as: rhinitis allergic and was treated with Olopatadine Hcl(dosage: NA). The treatment was initiated on Sep 17, 2011. After that a consumer reported the following side effect(s):
  • Juvenile Arthritis
  • Hepatic Function Abnormal
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Olopatadine Hcl efficacy:
  • Methotrexate
  • Folic Acid
  • Prednisolone
  • Methotrexate
  • Adalimumab
  • Lansoprazole
  • Adalimumab
  • Prednisolone (15-30 Mg/day)
The patient was hospitalized.

Haematocrit Increased, Leukocytosis, Chronic Myeloid Leukaemia
In this report, Olopatadine Hcl was administered for the following condition: rhinitis allergic,gastrooesophageal reflux disease,right ventricular failure.A male consumer from JAPAN (weight: NA) started Olopatadine Hcl treatment (dosage: 10mg Per Day) on Jan 01, 1996.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Haematocrit Increased
  • Leukocytosis
  • Chronic Myeloid Leukaemia
A possible interaction with other drugs could have contributed to this reaction:
  • Rabeprazole Sodium (10mg Per Day)
  • Torsemide (8mg Per Day)
  • Lisinopril (10mg Per Day)
  • Ethyl Icosapentate (1800mg Per Day)
  • Allopurinol (100mg Per Day)
  • Flolan
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Olopatadine Hcl treatment could be related to the listed above side effect(s).

Loss Of Consciousness, Nausea, Vomiting
This is a report of the following Olopatadine Hcl side effect(s):
  • Loss Of Consciousness
  • Nausea
  • Vomiting
A 69-year-old female patient from JAPAN (weight: NA) presented with the following condition: NA and received a treatment with Olopatadine Hcl (dosage: 10 Mg, 1x/day) starting: Jan 11, 2012.The following concurrently used drugs could have generated interactions:
  • Lyrica (50 Mg, 2x/day)
  • Mucodyne (1000 Mg, 1x/day)
  • Cleanal (400 Mg, 1x/day)
The patient was hospitalized.This report suggests that a Olopatadine Hcl treatment could be associated with the listed above side effect(s).

Hepatic Neoplasm Malignant, Pyrexia, Neutrophil Count Increased, Hepatic Function Abnormal, Insomnia, Hypertension, Constipation
This Olopatadine Hcl report was submitted by a 54-year-old male consumer from JAPAN (weight: NA). The patient was diagnosed with: NA and Olopatadine Hcl was administered (dosage: Daily Dose 10 Mg) starting: Oct 29, 2011. The consumer developed a set of symptoms:
  • Hepatic Neoplasm Malignant
  • Pyrexia
  • Neutrophil Count Increased
  • Hepatic Function Abnormal
  • Insomnia
  • Hypertension
  • Constipation
Other drugs used simultaneously:
  • Atarax (Daily Dose 50 Mg)
  • Nexavar (400 Mg, Qd)
  • Lansoprazole (Daily Dose 15 Mg)
  • Hirudoid (Unk)
Those unexpected symptoms could be linked to a Olopatadine Hcl treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Blood Glucose Increased
This is a report of a possible correlation between Olopatadine Hcl use and the following symptoms/side effect(s):
  • Blood Glucose Increased
which could contribute to an assessment of Olopatadine Hcl risk profile.A 73-year-old male consumer from JAPAN (weight: NA) was suffering from NA and was treated with Olopatadine Hcl (dosage: NA) starting Nov 02, 2011.Other concurrent medications:
  • Antithrombotic Agents
  • Coniel
  • Plavix
  • Anplag
  • Aspirin
  • Basen
  • Anplag
  • Tricor
The patient was hospitalized.

Blood Albumin Decreased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Epstein-barr Virus Antibody Positive, Faeces Pale, Allergic Hepatitis, Prothrombin Time Prolonged, Malaise, Prothrombin Time Ratio Decreased
A 81-year-old female patient from JAPAN (weight: NA) presented with the following symptoms: pruritus and after a treatment with Olopatadine Hcl (dosage: NA) experienced the following side effect(s):
  • Blood Albumin Decreased
  • Aspartate Aminotransferase Increased
  • Blood Lactate Dehydrogenase Increased
  • Epstein-barr Virus Antibody Positive
  • Faeces Pale
  • Allergic Hepatitis
  • Prothrombin Time Prolonged
  • Malaise
  • Prothrombin Time Ratio Decreased
The treatment was started on Nov 14, 2011. Olopatadine Hcl was used in combination with the following drugs:
  • Atarax
  • Xyzal
  • Celestamine Tab
The patient was hospitalized.This report could alert potential Olopatadine Hcl consumers.

Laceration
In this report, a 71-year-old female patient from JAPAN (weight: NA) was affected by a possible Olopatadine Hcl side effect.The patient was diagnosed with pruritus. After a treatment with Olopatadine Hcl (dosage: 5 Mg, 2x/day, start date: NS), the patient experienced the following side effect(s):
  • Laceration
The following simultaneously used drugs could have led to this reaction:
  • Hirudoid (Unk)
  • Drenison (Unk)
  • Lipitor (10 Mg, Uid/qd)
The findings here stress that side effects should be taken into consideration when evaluating a Olopatadine Hcl treatment.

Pain, Myocardial Infarction, Cerebrovascular Accident, Pulmonary Embolism, Anxiety, Gallbladder Disorder, Deep Vein Thrombosis, Cholecystitis Acute, Cholecystitis Chronic
This is a report of a 25-year-old female patient from UNITED STATES (weight: NA), who used Olopatadine Hydrochloride (dosage: Unk Unk, Prn) for a treatment of NA. After starting a treatment on Jan 01, 2001, the patient experienced the following side effect(s):
  • Pain
  • Myocardial Infarction
  • Cerebrovascular Accident
  • Pulmonary Embolism
  • Anxiety
  • Gallbladder Disorder
  • Deep Vein Thrombosis
  • Cholecystitis Acute
  • Cholecystitis Chronic
The following drugs could possibly have interacted with the Olopatadine Hydrochloride treatment
  • Xanax (Unk)
  • Drospirenone And Ethinyl Estradiol (Unk)
  • Prednisone (Unk)
  • Pepcid (Unk Unk, Qd)
  • Yasmin (Unk)
  • Advair Diskus 100/50 (Unk)
  • Allegra
  • Flonase
Taken together, these observations suggest that a Olopatadine Hydrochloride treatment could be related to side effect(s), such as Pain, Myocardial Infarction, Cerebrovascular Accident, Pulmonary Embolism, Anxiety, Gallbladder Disorder, Deep Vein Thrombosis, Cholecystitis Acute, Cholecystitis Chronic.

Dyspnoea, Burning Sensation
This dyspnoea side effect was reported by a consumer or non-health professional from UNITED STATES. A male patient (weight:NA) experienced the following symptoms/conditions: hypersensitivity. The patient was prescribed Olopatadine Hydrochloride (dosage: NA), which was started on NS. Concurrently used drugs:
  • Fluticasone Propionate
  • Proair Hfa
When starting to take Olopatadine Hydrochloride the consumer reported the following symptoms:
  • Dyspnoea
  • Burning Sensation
These side effects may potentially be related to Olopatadine Hydrochloride.

Pulmonary Artery Thrombosis, Venous Thrombosis
This is a Olopatadine Hcl side effect report of a 29-year-old female patient (weight:NA) from JAPAN, suffering from the following symptoms/conditions: pruritus,non-small cell lung cancer,constipation, who was treated with Olopatadine Hcl (dosage:1 Tablet, As Needed, start time: Sep 21, 2010), combined with:
  • Crizotinib (250 Mg, 2x/day)
  • Milmag (2 Tablets, As Needed)
  • Kindavate (As Needed)
, and developed a serious reaction and a pulmonary artery thrombosis side effect. The patient presented with:
  • Pulmonary Artery Thrombosis
  • Venous Thrombosis
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Olopatadine Hcl treatment in female patients suffering from pruritus,non-small cell lung cancer,constipation, resulting in pulmonary artery thrombosis.

Jaw Disorder, Paralysis, Viith Nerve Paralysis, Apraxia, Tenderness, Cranial Nerve Palsies Multiple, Temporomandibular Joint Syndrome, Dysphagia, Trismus
This report suggests a potential Olopatadine Hcl jaw disorder side effect(s) that can have serious consequences. A 75-year-old male patient from JAPAN (weight:NA) was diagnosed with the following health condition(s): NA and used Olopatadine Hcl (dosage: NA) starting Sep 02, 2011. Soon after starting Olopatadine Hcl the patient began experiencing various side effects, including:
  • Jaw Disorder
  • Paralysis
  • Viith Nerve Paralysis
  • Apraxia
  • Tenderness
  • Cranial Nerve Palsies Multiple
  • Temporomandibular Joint Syndrome
  • Dysphagia
  • Trismus
Drugs used concurrently:
  • Mucosta
  • Cefazolin Sodium (Dosage Form: Powder)
  • Methaderm
  • Ferrum
  • Xyzal
  • Tranexamic Acid
  • Xyzal
  • Bio-three
The patient was hospitalized and became disabled. Although Olopatadine Hcl demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as jaw disorder, may still occur.

Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Hepatic Function Abnormal
This aspartate aminotransferase increased problem was reported by a physician from JAPAN. A 71-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Aug 17, 2006 a consumer started treatment with Olopatadine Hcl (dosage: NA). The following drugs/medications were being taken at the same time:
  • Allopurinol
  • Arava
  • Uralyt
  • Azulfidine
  • Flivas
  • S. Adchnon
  • Comelian
When commencing Olopatadine Hcl, the patient experienced the following unwanted symptoms /side effects:
  • Aspartate Aminotransferase Increased
  • Alanine Aminotransferase Increased
  • Hepatic Function Abnormal
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as aspartate aminotransferase increased, may become evident only after a product is in use by the general population.

White Blood Cell Count Increased, Haematocrit Increased
This is a Olopatadine Hcl side effect report of a male patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: rhinitis allergic,pulmonary arterial hypertension,hyperuricaemia,right ventricular failure,dyslipidaemia and was treated with Olopatadine Hcl (dosage: 10mg Per Day) starting Jul 02, 2009. Concurrently used drugs:
  • Flolan
  • Allopurinol (100mg Per Day)
  • Torsemide (8mg Per Day)
  • Ethyl Icosapentate (1800mg Per Day)
  • Lisinopril (10mg Per Day)
  • Rabeprazole Sodium (10mg Per Day)
Soon after that, the consumer experienced the following of symptoms:
  • White Blood Cell Count Increased
  • Haematocrit Increased
This opens a possibility that Olopatadine Hcl could cause white blood cell count increased and that some male patients may be more susceptible.

Thyroid Cancer
A 37-year-old female patient (weight: NA) from JAPAN with the following symptoms: NA started Olopatadine Hcl treatment (dosage: NA) on Feb 09, 2011. Soon after starting Olopatadine Hcl treatment, the consumer experienced several side effects, including:
  • Thyroid Cancer
. Concurrently used drugs:
  • Solostar
  • Metformin Hydrochloride (2 Tab Each After Breakfast And Supper)
  • Lantus
  • Lantus
  • Exenatide
  • Metformin Hydrochloride (After Breakfast)
  • Lantus
  • Metformin Hydrochloride (1 Tab Each After Breakfast And Supper)
This finding indicates that some patients can be more vulnerable to developing Olopatadine Hcl side effects, such as thyroid cancer.

Dermatitis Bullous
This dermatitis bullous side effect was reported by a physician from JAPAN. A 66-year-old female patient (weight:NA) experienced the following symptoms/conditions: hypersensitivity,hypertension.The patient was prescribed Olopatadine Hcl (dosage: NA), which was started on Jan 01, 2005. Concurrently used drugs:
  • Cozaar
  • Carvedilol
  • Mucosta
.When starting to take Olopatadine Hcl the consumer reported symptoms, such as:
  • Dermatitis Bullous
These side effects may potentially be related to Olopatadine Hcl.

Thrombotic Cerebral Infarction, Decreased Appetite
This is a report of a 77-year-old female patient (weight: NA) from JAPAN, suffering from the following symptoms/conditions: pruritus, who was treated with Olopatadine Hcl (dosage: 10 Mg, Qd, start time: May 28, 2011), combined with:
  • Victoza (0.6 Mg, Qd)
  • Victoza (0.9 Mg, Qd)
  • Amaryl (3 Mg, Qd)
  • Lasix (20 Mg, Qd)
  • Norvasc (5 Mg, Qd)
  • Sunrythm (75 Mg, Qd)
  • Digoxin (0.125 Mg, Qd)
  • Preran (1 Mg, Qd)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Thrombotic Cerebral Infarction
  • Decreased Appetite
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Olopatadine Hcl treatment in female patients, resulting in thrombotic cerebral infarction side effect. The patient was hospitalized.

Aspartate Aminotransferase Increased, Hypersensitivity, Alanine Aminotransferase Increased, Eczema Asteatotic, Lymphocyte Count Decreased, Blood Amylase Increased, Rash, Blood Creatinine Increased
This report suggests a potential Olopatadine Aspartate Aminotransferase Increased, Hypersensitivity, Alanine Aminotransferase Increased, Eczema Asteatotic, Lymphocyte Count Decreased, Blood Amylase Increased, Rash, Blood Creatinine Increased side effect(s) that can have serious consequences. A male patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: NA and used Olopatadine (dosage: NA) starting Dec 27, 2010. Soon after starting Olopatadine the patient began experiencing various side effects, including:
  • Aspartate Aminotransferase Increased
  • Hypersensitivity
  • Alanine Aminotransferase Increased
  • Eczema Asteatotic
  • Lymphocyte Count Decreased
  • Blood Amylase Increased
  • Rash
  • Blood Creatinine Increased
Drugs used concurrently:
  • Granisetron Hcl
  • Prednisolone
  • Levofloxacin
  • Famotidine
  • Bendamustine Hcl
  • Difluprednate
  • Brotizolam
  • Bendamustine Hcl
The patient was hospitalized. Although Olopatadine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as aspartate aminotransferase increased, may still occur.

Hepatitis Acute
This Hepatitis Acute problem was reported by a physician from JAPAN. A 22-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Olopatadine Hcl (dosage: NA). The following drugs were being taken at the same time:
  • Allegra
When commencing Olopatadine Hcl, the patient experienced the following unwanted symptoms/side effects:
  • Hepatitis Acute
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as hepatitis acute, may become evident only after a product is in use by the general population.

Product Formulation Issue, Bone Pain, Asthenia, Viral Infection
This is a report of a 54-year-old male patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: NA and was treated with Olopatadine (dosage: NA) starting Jun 01, 2010. Concurrently used drugs:
  • Aspirin
  • Lasix
  • Prolastin-c (5900 Mg, Qw, Iv)
  • Prolastin
  • Albuterol
  • Xanax
  • Advair Diskus 100/50
Soon after that, the consumer experienced the following side effects:
  • Product Formulation Issue
  • Bone Pain
  • Asthenia
  • Viral Infection
This opens a possibility that Olopatadine treatment could cause the above reactions, including product formulation issue, and some male subjects may be more susceptible.

White Blood Cell Count Increased, Pain Of Skin, Pyrexia, Mobility Decreased, Arthralgia, Hyperuricaemia, C-reactive Protein Increased, Erythrodermic Psoriasis
A 51-year-old male patient (weight: NA) from JAPAN with the following symptoms/conditions: dermatitis exfoliative,reflux oesophagitis,hypertension started Olopatadine Hydrochloride treatment (dosage: NA) on Nov 24, 2005. Soon after starting Olopatadine Hydrochloride treatment, the subject experienced various side effects, including:
  • White Blood Cell Count Increased
  • Pain Of Skin
  • Pyrexia
  • Mobility Decreased
  • Arthralgia
  • Hyperuricaemia
  • C-reactive Protein Increased
  • Erythrodermic Psoriasis
Concurrently used drugs:
  • Lansoprazole
  • Enalapril Maleate
  • White Petroleum (Qs)
  • Carvedilol
  • Heparin (Qs)
  • Metenolone
  • Betamethasone Sodium Phosphate (Qs)
  • Ofloxacin (Qs)
The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Olopatadine Hydrochloride.

1 of 2 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Olopatadine Side Effects

    Did You Have a Olopatadine Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Olopatadine for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Olopatadine Safety Alerts, Active Ingredients, Usage Information

    More About Olopatadine

    Side Effects reported to FDA: 28

    Olopatadine safety alerts: No

    Reported deaths: 2

    Reported hospitalizations: 13

    Latest Olopatadine clinical trials

    Olopatadine Reviews

    No reviews, be a first to report a side effect via side effect reporting form